🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
To demonstrate the safety, pharmacokinetics and pharmacodynamics of drug ca...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2009-03
Trial ID
NCT00856258
Treatments Being Tested
To evaluate the safety and tolerability of PF-03882845 in Healthy Volunteer...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2009-09
Trial ID
NCT00971802
Treatments Being Tested
The primary purpose of this study is to estimate the relative bioavailabili...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-01
Trial ID
NCT01366287
Treatments Being Tested
PF-03882845 is a compound proposed for treatment of type 2 diabetic nephrop...
Status
Terminated
Location
Pfizer Investigational Site
Start Date
2012-01
Trial ID
NCT01488877
Treatments Being Tested
The purpose of this study is to estimate the effect of multiple oral doses ...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-08
Trial ID
NCT01445860
Treatments Being Tested
24-hr urinary sodium/potassium ratio will be a sensitive biomarker of antim...
Status
Completed
Location
Pfizer Investigational Site
Start Date
2011-03
Trial ID
NCT01314898
Treatments Being Tested